Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Debt / NOTE 4.000% 4/0
-
Unit price / market price
-
$0.7000
-
Total 13F principal
-
$92,440,000
-
Principal change
-
$0
-
Total reported value
-
$65,609,000
-
Number of holders
-
3
Institutional Holders of TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 as of Q1 2020
As of 31 Mar 2020 TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 had 3 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $92,440,000 principal (par value or face value) of the bond of the company.
Largest 3 bondholders included STONEHILL CAPITAL MANAGEMENT LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, and CITADEL ADVISORS LLC.
This table shows 3 bond principal holders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.